Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377191 | 12537719 | 1 | I | 20131107 | 20151016 | 20160707 | 20160707 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2015VAL000672 | VALIDUS | 0.00 | Y | 0.00000 | 20160707 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377191 | 12537719 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | U | 17963 | ||||||||||
| 125377191 | 12537719 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 4 WEEKS) | Y | 0 | 20 | MG | |||||||
| 125377191 | 12537719 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | Y | 0 | 30 | MG | |||||||
| 125377191 | 12537719 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK, BID FOR 6 WEEKS | U | 0 | |||||||||
| 125377191 | 12537719 | 5 | C | RANITIDINE. | RANITIDINE | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 6 | C | LYRICA | PREGABALIN | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 7 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 8 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 9 | C | COGENTIN | BENZTROPINE MESYLATE | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 10 | C | IRON | IRON | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 11 | C | MEXIRAN | 2 | UNK | U | 0 | |||||||||||
| 125377191 | 12537719 | 12 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 13 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125377191 | 12537719 | 14 | C | MODECATE | FLUPHENAZINE DECANOATE | 1 | UNK | U | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125377191 | 12537719 | 1 | Product used for unknown indication |
| 125377191 | 12537719 | 2 | Metastatic carcinoid tumour |
| 125377191 | 12537719 | 4 | Product used for unknown indication |
| 125377191 | 12537719 | 5 | Product used for unknown indication |
| 125377191 | 12537719 | 6 | Product used for unknown indication |
| 125377191 | 12537719 | 7 | Product used for unknown indication |
| 125377191 | 12537719 | 8 | Product used for unknown indication |
| 125377191 | 12537719 | 9 | Product used for unknown indication |
| 125377191 | 12537719 | 10 | Product used for unknown indication |
| 125377191 | 12537719 | 11 | Product used for unknown indication |
| 125377191 | 12537719 | 12 | Product used for unknown indication |
| 125377191 | 12537719 | 13 | Product used for unknown indication |
| 125377191 | 12537719 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125377191 | 12537719 | DE |
| 125377191 | 12537719 | HO |
| 125377191 | 12537719 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125377191 | 12537719 | Abscess | |
| 125377191 | 12537719 | Blood pressure increased | |
| 125377191 | 12537719 | Blood pressure systolic increased | |
| 125377191 | 12537719 | Death | |
| 125377191 | 12537719 | Decreased appetite | |
| 125377191 | 12537719 | Diarrhoea | |
| 125377191 | 12537719 | Fall | |
| 125377191 | 12537719 | Fatigue | |
| 125377191 | 12537719 | Flatulence | |
| 125377191 | 12537719 | Full blood count decreased | |
| 125377191 | 12537719 | Gastric cancer | |
| 125377191 | 12537719 | Haemoglobin decreased | |
| 125377191 | 12537719 | Influenza | |
| 125377191 | 12537719 | Malaise | |
| 125377191 | 12537719 | Malignant neoplasm progression | |
| 125377191 | 12537719 | Metastases to liver | |
| 125377191 | 12537719 | Muscle spasms | |
| 125377191 | 12537719 | Nasopharyngitis | |
| 125377191 | 12537719 | Neoplasm | |
| 125377191 | 12537719 | Post procedural infection | |
| 125377191 | 12537719 | Respiratory tract infection | |
| 125377191 | 12537719 | Second primary malignancy | |
| 125377191 | 12537719 | Sleep disorder | |
| 125377191 | 12537719 | Vomiting | |
| 125377191 | 12537719 | Weight decreased | |
| 125377191 | 12537719 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125377191 | 12537719 | 2 | 20101018 | 0 | ||
| 125377191 | 12537719 | 4 | 20100920 | 0 |